Hyperlipidemia after allogeneic stem cell transplantation: prevalence, risk factors, and impact on prognosis

Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management

(2010) M. L. Griffith et al.   BLOOD

How I treat late effects in adults after allogeneic stem cell transplantation

(2010) B. N. Savani et al.   BLOOD

Frequency of Abnormal Findings Detected by Comprehensive Clinical Evaluation at 1 Year after Allogeneic Hematopoietic Cell Transplantation

(2009) Stephanie J. Lee et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens

(2009) Y R Abou-Mourad et al.   BONE MARROW TRANSPLANTATION

Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment

(2009) Inga Soveri et al.   CLINICAL TRANSPLANTATION

Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation

(2008) C Annaloro et al.   BONE MARROW TRANSPLANTATION

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

(2008) A. Tichelli et al.   HAEMATOLOGICA

Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver

(2008) Hanaa Zidan et al.   PEDIATRIC BLOOD & CANCER